Form 4: Jaguar Health Executive Jonathan S. Wolin Reports Stock Transactions
SEC Form 4 Filing
Jonathan S. Wolin, Chief of Staff, CCO & GC of Jaguar Health, Inc., reported the acquisition and disposal of common stock and restricted stock units on April 5, 2024.
Summary
- On April 5, 2024, Jonathan S. Wolin, Chief of Staff, CCO & GC of Jaguar Health, Inc., reported transactions involving the company's stock.
- Wolin acquired 89 restricted stock units that convert into common stock on a one-for-one basis.
- Wolin also disposed of 1,141 shares of common stock.
- The restricted stock units were granted on April 5, 2021, and vest in three equal annual installments beginning on April 5, 2022.
- The reported transactions reflect adjustments due to previous reverse stock splits.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders.
Stakeholder Impact
- Shareholders can use this information to understand the actions of company insiders and their potential impact on the stock's performance.
Key Dates
| Date | Description |
|---|---|
| September 8, 2021 | Issuer effected a 3-for-1 reverse stock split. |
| April 5, 2021 | Restricted stock units were granted. |
| April 5, 2022 | First vesting date of restricted stock units. |
| January 23, 2023 | Issuer effected a 75-for-1 reverse stock split. |
| April 5, 2024 | Date of reported stock transactions (acquisition and disposal). |
| April 17, 2024 | Date of signature on the Form 4 filing. |
Keywords
Jaguar Health, Jonathan S. Wolin, Form 4, Stock Transactions, Restricted Stock Units, Common Stock, Reverse Stock Split, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.